论文部分内容阅读
目的:观察射干麻黄汤联合阿斯美治疗咳嗽变异型哮喘的临床疗效。方法:咳嗽变异型哮喘患者62例随机分为治疗组32例与对照组30例。治疗组给予射干麻黄汤联合阿斯美治疗,对照组给予硫酸沙丁胺醇气雾剂联合酮替芬治疗,疗程均为2周。比较2组治疗前后咳嗽症状缓解情况及最大呼气流量占预计值百分比、最大呼气流量变异率。结果:2组治疗后最大呼气流量占预计值百分比、最大呼气流量变异率均较治疗前改善(P<0.05或P<0.01),咳嗽症状评分较治疗前降低(P<0.01);2组治疗后最大呼气流量占预计值百分比、最大呼气流量变异率比较差异无统计学意义(P>0.05),治疗组咳嗽症状评分降低优于对照组(P<0.05)。结论:射干麻黄汤联合阿斯美治疗咳嗽变异性哮喘效果满意。
Objective: To observe the clinical efficacy of Shegan Mahuang combined with Asme in the treatment of Cough variant asthma. Methods: 62 patients with cough variant asthma were randomly divided into treatment group (32 cases) and control group (30 cases). The treatment group was given Shegan Mahuang Decoction combined with aspirin, while the control group was given salbutamol sulfate aerosol combined with ketotifen for two weeks. The relief of cough and the ratio of the maximum expiratory flow to the predicted value and the maximum expiratory flow rate were compared between the two groups before and after treatment. Results: The maximal expiratory flow rate, percentage of maximum expiratory flow rate, and the maximum expiratory flow rate in both groups were significantly improved after treatment (P <0.05 or P <0.01). The cough symptom score was lower than that before treatment (P <0.01). 2 The maximum expiratory flow after treatment was as a percentage of the predicted value, and the maximum expiratory flow rate had no significant difference (P> 0.05). The cough symptom score in the treatment group was lower than that in the control group (P <0.05). Conclusion: Shegan Mahuang Decoction combined with Asmes treatment of cough variant asthma with satisfactory results.